Rhie SK, Yao L, Luo Z, Witt H, Schreiner S, Guo Y, Perez AA, Farnham PJ. ZFX acts as a transcriptional activator in multiple types of human tumors by binding downstream of transcription start sites at the majority of CpG island promoters. Genome Res. 2018;28(3):310–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ni W, Perez AA, Schreiner S, Nicolet CM, Farnham PJ. Characterization of the ZFX family of transcription factors that bind downstream of the start site of CpG island promoters. Nucleic Acids Res. 2020;48(11):5986–6000.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Teif VB, Vainshtein Y, Caudron-Herger M, Mallm JP, Marth C, Höfer T, Rippe K. Genome-wide nucleosome positioning during embryonic stem cell development. Nat Struct Mol Biol. 2012;19(11):1185–92.

Article  CAS  PubMed  Google Scholar 

Gokhman D, Livyatan I, Sailaja BS, Melcer S, Meshorer E. Multilayered chromatin analysis reveals E2f, Smad and Zfx as transcriptional regulators of histones. Nat Struct Mol Biol. 2013;20(1):119–26.

Article  CAS  PubMed  Google Scholar 

Galan-Caridad JM, Harel S, Arenzana TL, Hou ZE, Doetsch FK, Mirny LA, Reizis B. Zfx controls the self-renewal of embryonic and hematopoietic stem cells. Cell. 2007;129(2):345–57.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu G, Kim J, Xu Q, Leng Y, Orkin SH, Elledge SJ. A genome-wide RNAi screen identifies a new transcriptional module required for self-renewal. Genes Dev. 2009;23(7):837–48.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Smith-Raska MR, Arenzana TL, D’Cruz LM, Khodadadi-Jamayran A, Tsirigos A, Goldrath AW, Reizis B. The transcription factor Zfx regulates peripheral T cell self-renewal and proliferation. Front Immunol. 2018;9:1482.

Article  PubMed  PubMed Central  Google Scholar 

Palmer CJ, Galan-Caridad JM, Weisberg SP, Lei L, Esquilin JM, Croft GF, Wainwright B, Canoll P, Owens DM, Reizis B. Zfx facilitates tumorigenesis caused by activation of the Hedgehog pathway. Cancer Res. 2014;74(20):5914–24.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou Y, Su Z, Huang Y, Sun T, Chen S, Wu T, Chen G, Xie X, Li B, Du Z. The Zfx gene is expressed in human gliomas and is important in the proliferation and apoptosis of the human malignant glioma cell line U251. J Exp Clin Cancer Res. 2011;30(1):114.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fang X, Huang Z, Zhou W, Wu Q, Sloan AE, Ouyang G, McLendon RE, Yu JS, Rich JN, Bao S. The zinc finger transcription factor ZFX is required for maintaining the tumorigenic potential of glioblastoma stem cells. Stem Cells. 2014;32(8):2033–47.

Article  CAS  PubMed  Google Scholar 

Fang J, Yu Z, Lian M, Ma H, Tai J, Zhang L, Han D. Knockdown of zinc finger protein, X-linked (ZFX) inhibits cell proliferation and induces apoptosis in human laryngeal squamous cell carcinoma. Mol Cell Biochem. 2012;360(1–2):301–7.

Article  CAS  PubMed  Google Scholar 

Jiang H, Zhang L, Liu J, Chen Z, Na R, Ding G, Zhang H, Ding Q. Knockdown of zinc finger protein X-linked inhibits prostate cancer cell proliferation and induces apoptosis by activating caspase-3 and caspase-9. Cancer Gene Ther. 2012;19(10):684–9.

Article  CAS  PubMed  Google Scholar 

Cai L, Tsai YH, Wang P, Wang J, Li D, Fan H, Zhao Y, Bareja R, Lu R, Wilson EM, Sboner A, Whang YE, Zheng D, Parker JS, Earp HS, Wang GG. ZFX mediates non-canonical oncogenic functions of the androgen receptor splice variant 7 in castrate-resistant prostate cancer. Mol Cell. 2018;72(2):341-354.e6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Akiyoshi S, Fukagawa T, Ueo H, Ishibashi M, Takahashi Y, Fabbri M, Sasako M, Maehara Y, Mimori K, Mori M. Clinical significance of miR-144-ZFX axis in disseminated tumour cells in bone marrow in gastric cancer cases. Br J Cancer. 2012;107(8):1345–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu S, Lao XY, Sun TT, Ren LL, Kong X, Wang JL, Wang YC, Du W, Yu YN, Weng YR, Hong J, Fang JY. Knockdown of ZFX inhibits gastric cancer cell growth in vitro and in vivo via downregulating the ERK-MAPK pathway. Cancer Lett. 2013;337(2):293–300.

Article  CAS  PubMed  Google Scholar 

Weisberg SP, Smith-Raska MR, Esquilin JM, Zhang J, Arenzana TL, Lau CM, Churchill M, Pan H, Klinakis A, Dixon JE, Mirny LA, Mukherjee S, Reizis B. ZFX controls propagation and prevents differentiation of acute T-lymphoblastic and myeloid leukemia. Cell Rep. 2014;6(3):528–40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu J, Wei B, Wang Q, Ding Y, Deng Z, Lu X, Li Y. ZFX facilitates cell proliferation and imatinib resistance in chronic myeloid leukemia cells. Cell Biochem Biophys. 2016;74(2):277–83.

Article  CAS  PubMed  Google Scholar 

Wu J, Xiao L, Zhou H, Liu H, Ge Y, Yang J, Li Y, Wu D, Zhao Y, Zhang X. ZFX modulates the growth of human leukemic cells via B4GALT1. Acta Biochim Biophys Sin. 2016;48(12):1120–7.

Article  CAS  PubMed  Google Scholar 

Zha W, Cao L, Shen Y, Huang M. Roles of Mir-144-ZFX pathway in growth regulation of non-small-cell lung cancer. PLoS ONE. 2013;8(9): e74175.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiang J, Liu LY. Zinc finger protein X-linked is overexpressed in colorectal cancer and is associated with poor prognosis. Oncol Lett. 2015;10(2):810–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lai KP, Chen J, He M, Ching AK, Lau C, Lai PB, To KF, Wong N. Overexpression of ZFX confers self-renewal and chemoresistance properties in hepatocellular carcinoma. Int J Cancer. 2014;135(8):1790–9.

Article  CAS  PubMed  Google Scholar 

Wang C, Fu SY, Wang MD, Yu WB, Cui QS, Wang HR, Huang H, Dong W, Zhang WW, Li PP, Lin C, Pan ZY, Yang Y, Wu MC, Zhou WP. Zinc finger protein X-linked promotes expansion of EpCAM+ cancer stem-like cells in hepatocellular carcinoma. Mol Oncol. 2017;11(5):455–69.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li C, Li H, Zhang T, Li J, Ma F, Li M, Sui Z, Chang J. ZFX is a strong predictor of poor prognosis in renal cell carcinoma. Med Sci Monit. 2015;21:3380–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Han C, Li X, Fan Q, Liu G, Yin J. CCAT1 promotes triple-negative breast cancer progression by suppressing miR-218/ZFX signaling. Aging. 2019;11(14):4858–75.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sloma I, Jiang X, Eaves AC, Eaves CJ. Insights into the stem cells of chronic myeloid leukemia. Leukemia. 2010;24(11):1823–33.

Article  CAS  PubMed  Google Scholar 

Mughal TI, Radich JP, Deininger MW, Apperley JF, Hughes TP, Harrison CJ, Gambacorti-Passerini C, Saglio G, Cortes J, Daley GQ. Chronic myeloid leukemia: reminiscences and dreams. Haematologica. 2016;101(5):541–58.

Article  CAS  PubMed  PubMed Central  Google Scholar 

MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009;17(1):9–26.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nusse R, Clevers H. Wnt/β-catenin signaling, disease, and emerging therapeutic modalities. Cell. 2017;169(6):985–99.

Article  CAS  PubMed  Google Scholar 

Liu J, Xiao Q, Xiao J, Niu C, Li Y, Zhang X, Zhou Z, Shu G, Yin G. Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther. 2022;7(1):3.

Article  PubMed  PubMed Central  Google Scholar 

Anwar M, Malhotra P, Kochhar R, Bhatia A, Mahmood A, Singh R, Mahmood S. TCF 4 tumor suppressor: a molecular target in the prognosis of sporadic colorectal cancer in humans. Cell Mol Biol Lett. 2020;25:24.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ge X, Wang X. Role of Wnt canonical pathway in hematological malignancies. J Hematol Oncol. 2010;3:33.

Article  PubMed  PubMed Central  Google Scholar 

Zhao C, Blum J, Chen A, Kwon HY, Jung SH, Cook JM, Lagoo A, Reya T. Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo. Cancer Cell. 2007;12(6):528–41.

Article  CAS  PubMed  PubMed Central  Google Scholar